top of page
Starting August 1, 2024, Quickarrays Inc. will be taking over Pantomics Inc. to
provide all products and services. Please visit Quickarrays Inc. for more information.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
Hermatopathology
LVC1021
Liver cancer tissue array, 102 cases of normal/benign (5 cases) and cancer (97 cases) tissues with grading and TNM staging data
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
$289
1 slide
In-Stock
A | |
B | |
C | |
D | |
E | |
F | |
G | |
H | |
TNM Classification : Liver carcinoma
T- Primary tumor
TX - Primary tumor cannot be assessed
TO - No evidence of primary tumor
T1 - Solitary tumor without vascular invasion
T2 - Solitary tumor with vascular invasion or multiple tumors none larger than 5cm
T3 - Multiple tumors more than 5 cm, or tumor involving a major branch of the portal or hepatic vein(s)
T4 - Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum
N - Regional lymph nodes
NX - Regional lymph nodes cannot be assessed
NO - No regional lymph node metastasis
N1 - Regional lymph node metastasis
M - Distant metastasis
MX - Distant metastasis cannot be assessed
MO - No distant metastasis
M1 - Distant metastasis
Human
102
102
1.5mm
4um
8
13
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in liver cancers.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
|---|---|---|---|---|---|---|---|
A01 | M | 68 | Liver | Normal | |||
A02 | F | 67 | Liver | Normal | |||
A03 | M | 52 | Liver | Hepatitis | |||
A04 | F | 64 | Liver | Hemangioma | |||
A05 | M | 37 | Liver | Hemangioma | |||
A06 | M | 36 | Liver | Hepatocellular carcinoma | I | T3N0M0 | |
A07 | M | 45 | Liver | Hepatocellular carcinoma | I | T3N0M0 | |
A08 | M | 26 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
A09 | M | 50 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
A10 | M | 48 | Liver | Hepatocellular carcinoma | I | T2N0M0 | |
A11 | M | 52 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
A12 | M | 62 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
A13 | M | 45 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B01 | M | 40 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B02 | M | 61 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B03 | M | 40 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B04 | M | 56 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B05 | M | 19 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B06 | M | 48 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B07 | M | 49 | Liver | Hepatocellular carcinoma | I~II | T3N0M0 | |
B08 | M | 43 | Liver | Hepatocellular carcinoma | I~II | T3N0M0 | |
B09 | M | 30 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B10 | M | 59 | Liver | Hepatocellular carcinoma | I~II | T2N0M0 | |
B11 | M | 40 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
B12 | M | 47 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
B13 | F | 35 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C01 | M | 47 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C02 | M | 41 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C03 | M | 57 | Liver | Hepatocellular carcinoma | II | T3N1M0 | |
C04 | M | 41 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C05 | M | 33 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C06 | M | 35 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C07 | M | 42 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C08 | F | 35 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
C09 | M | 38 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C10 | M | 30 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C11 | M | 77 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C12 | M | 41 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
C13 | M | 26 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D01 | M | 59 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D02 | M | 52 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D03 | M | 53 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D04 | M | 41 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D05 | M | 69 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D06 | M | 76 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D07 | M | 56 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D08 | M | 49 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D09 | M | 59 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D10 | M | 78 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
D11 | M | 44 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D12 | M | 32 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
D13 | M | 36 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E01 | M | 50 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E02 | M | 63 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E03 | M | 35 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
E04 | M | 29 | Liver | Hepatocellular carcinoma | II | T4N0M0 | |
E05 | M | 40 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E06 | F | 73 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
E07 | F | 60 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E08 | M | 18 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E09 | M | 41 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
E10 | M | 17 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E11 | M | 67 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E12 | F | 52 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
E13 | M | 44 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
F01 | M | 40 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F02 | M | 56 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
F03 | M | 31 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
F04 | M | 58 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F05 | M | 49 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F06 | M | 48 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F07 | M | 36 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F08 | M | 58 | Liver | Hepatocellular carcinoma | II | T3N0M0 | |
F09 | M | 44 | Liver | Hepatocellular carcinoma | II | T2N0M0 | |
F10 | M | 48 | Liver | Hepatocellular carcinoma | II~III | T3N0M0 | |
F11 | M | 33 | Liver | Hepatocellular carcinoma | II~III | T2N0M0 | |
F12 | M | 50 | Liver | Hepatocellular carcinoma | II~III | T3N0M0 | |
F13 | M | 53 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
G01 | F | 57 | Liver | Hepatocellular carcinoma | II~III | T4N1M1 | |
G02 | M | 61 | Liver | Hepatocellular carcinoma | II~III | T4N0M0 | |
G03 | M | 56 | Liver | Hepatocellular carcinoma | II~III | T3N0M0 | |
G04 | M | 57 | Liver | Hepatocellular carcinoma | II~III | T4N0M0 | |
G05 | M | 37 | Liver | Hepatocellular carcinoma | II~III | T2N0M0 | |
G06 | M | 38 | Liver | Hepatocellular carcinoma | II~III | T2N0M0 | |
G07 | M | 61 | Liver | Hepatocellular carcinoma | II~III | T4N1M1 | |
G08 | M | 53 | Liver | Hepatocellular carcinoma | II~III | T2N0M0 | |
G09 | M | 33 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
G10 | M | 65 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
G11 | M | 54 | Liver | Hepatocellular carcinoma | III | T4N1M0 | |
G12 | M | 31 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
H01 | M | 41 | Liver | Hepatocellular carcinoma | III | T2N0M0 | |
H02 | M | 30 | Liver | Cholangiocarcinoma | T2N0M0 | ||
H03 | F | 72 | Liver | Cholangiocarcinoma | T2N0M0 | ||
H04 | M | 70 | Liver | Cholangiocarcinoma | T2N0M0 | ||
H05 | F | 80 | Liver | Cholangiocarcinoma | T3N0M0 | ||
H06 | F | 69 | Liver | Cholangiocarcinoma | T4N1M0 | ||
H07 | M | 32 | Liver | Clear cell carcinoma | T3N0M0 | ||
H08 | M | 65 | Liver | Clear cell carcinoma | T2N0M0 | ||
H09 | M | 40 | Liver | Clear cell carcinoma | T2N0M0 | ||
H10 | M | 53 | Liver | Clear cell carcinoma | T3N0M0 | ||
H11 | M | 1.5 | Liver | Hepatoblastoma | |||
H12 | F | 45 | Liver | Sarcoma | |||
null |
Download Data Sheet
bottom of page